Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers
Development of Acceptance and Commitment Therapy for Cancer Distress Among Rural and Urban Patients With Hepatobiliary Cancers (ACT-HBC)
Mayo Clinic
60 participants
May 28, 2025
INTERVENTIONAL
Conditions
Summary
This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distress. Patients with hepatobiliary cancer (HBC) often experience high levels of distress and reductions in quality of life. ACT-HBC is a behavioral intervention tailored to patients with HBC. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.
Eligibility
Inclusion Criteria7
- HBC diagnosis
- Age >= 18 years
- Able to provide written informed consent
- Verbally endorse cancer distress
- Access to the internet
- Read and write in English
- Reside in the states of Iowa, Minnesota, or Wisconsin
Exclusion Criteria3
- Other psychological therapy that started =< 2 months prior to prospective enrollment
- Inability to actively participate in and learn from group therapy (e.g., active/uncontrolled psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgement in Behavioral Medicine Program (BMP) consultation. Individual therapy or alternative group therapy will be offered to patients ineligible per this criterion
- HBC remission
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Attend ACT-HBC telehealth group sessions
Ancillary studies
Attend ACT-HBC telehealth group sessions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07124546